D'ALESSIO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 659
NA - Nord America 570
EU - Europa 454
SA - Sud America 60
AF - Africa 41
Totale 1.784
Nazione #
US - Stati Uniti d'America 529
RU - Federazione Russa 228
SG - Singapore 209
CN - Cina 103
HK - Hong Kong 96
VN - Vietnam 73
BD - Bangladesh 72
IT - Italia 62
BR - Brasile 42
DE - Germania 36
FR - Francia 33
BJ - Benin 31
IN - India 27
KR - Corea 27
GB - Regno Unito 25
AT - Austria 19
CA - Canada 19
MX - Messico 17
ES - Italia 10
IQ - Iraq 10
JP - Giappone 10
AR - Argentina 9
PL - Polonia 9
FI - Finlandia 6
LT - Lituania 6
NL - Olanda 5
PH - Filippine 5
TR - Turchia 5
ZA - Sudafrica 5
EC - Ecuador 4
UA - Ucraina 4
PK - Pakistan 3
SE - Svezia 3
TW - Taiwan 3
CH - Svizzera 2
EG - Egitto 2
ID - Indonesia 2
LB - Libano 2
MA - Marocco 2
PY - Paraguay 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
BE - Belgio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.784
Città #
San Jose 141
Hong Kong 94
Singapore 90
Ashburn 79
Beijing 38
Cotonou 31
Los Angeles 29
Council Bluffs 27
Moscow 26
Lauterbourg 21
Santa Clara 20
Seoul 18
Hanoi 17
New York 17
Falkenstein 15
Ho Chi Minh City 15
Buffalo 13
Brooklyn 11
Mexico City 10
St Louis 10
Dallas 9
Orem 9
Gangbuk-gu 8
São Paulo 8
Tokyo 8
Vienna 8
Warsaw 8
Chennai 7
London 7
Novara 7
Toronto 7
Assago 6
Da Nang 6
Frankfurt am Main 6
Nuremberg 6
Haiphong 5
Montreal 5
Mumbai 5
Poplar 5
Tianjin 5
Boston 4
Columbus 4
Denver 4
Dhaka 4
Florence 4
Johannesburg 4
Manila 4
Milan 4
Phoenix 4
Shanghai 4
Ankara 3
Atlanta 3
Baghdad 3
Casier 3
Curitiba 3
Hangzhou 3
Helsinki 3
Long Xuyen 3
Quito 3
Seattle 3
Stockholm 3
Turin 3
Baie-D'Urfé 2
Bengaluru 2
Bologna 2
Botucatu 2
Bragança Paulista 2
Buenos Aires 2
Can Tho 2
Charlotte 2
Chicago 2
Cleveland 2
Córdoba 2
Delhi 2
Elk Grove Village 2
Genoa 2
Hillsboro 2
Jakarta 2
Lakeland 2
Lecce 2
Madrid 2
Manchester 2
Mosul 2
Naples 2
Palermo 2
Providence 2
Querétaro 2
Raleigh 2
Redondo Beach 2
Sabará 2
Sona 2
Thái Bình 2
Turku 2
Zurich 2
Aguascalientes 1
Ahmedabad 1
Amritsar 1
Amsterdam 1
América 1
Apodaca 1
Totale 1.003
Nome #
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 124
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 120
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 100
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma 94
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 94
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study 88
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 86
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 85
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 78
The price and value of therapeutic synergy in liver cancer 74
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison 73
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma 72
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma 71
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events 68
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer 65
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 63
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 63
Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply 60
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study 60
Immunotherapy at all stages of hepatocellular carcinoma 56
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden 56
Diabetes and Immune Checkpoint Inhibitors—Response 56
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma 53
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study 34
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence 27
Totale 1.820
Categoria #
all - tutte 6.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025400 5 0 5 2 4 7 45 106 98 37 13 78
2025/20261.420 56 33 48 120 192 102 205 182 119 164 77 122
Totale 1.820